がん診断におけるAIの世界市場レポート 2024

がん診断におけるAIの市場規模は、今後数年間で急激に成長すると予想されています。 2028年には20.3%の年間複合成長率（CAGR）で13億8,000万米ドルに成長すると予想されます。予測される成長は、説明可能なAIの出現、ヘルスケアIT支出の世界の増加、電子医療記録（EHR）との統合、個別化医療の導入、AIアルゴリズムの継続的な進歩に起因すると考えられます。予測期間の主な動向には、画像技術の進歩、技術の融合、ヘルスケア企業とテクノロジー企業のコラボレーション、デジタル病理学の台頭、病理組織学の自動化が含まれます。

がんの有病率の上昇により、将来、がん診断におけるAI市場の成長が促進されると予想されます。がんには、浸潤や転移を引き起こす可能性のある異常な細胞増殖を特徴とする一連の疾患が含まれます。 がん診断におけるAIの統合は、効率、精度、個別化された治療オプションを強化し、最終的にがん患者の転帰を改善することを目的としています。たとえば、国立医学図書館によると、世界のがん患者数は2040年までに2,840万件に達すると予測されており、これは2020年から47%増加し、それに伴う死亡者数も相当数に上ります。したがって、がんの有病率の増加は、がん診断市場における人工知能の拡大を推進する重要な要因となっています。

がん診断におけるAI市場の大手企業は、がん診断用のAIを活用したデジタル病理学ソリューションの進歩によって顕著な成長を遂げています。これらのソリューションは、AIアルゴリズムを利用してさまざまな組織タイプのがんやその他の診断特徴を検出し、正確かつタイムリーながん診断を提供し、症例の優先順位付けをサポートし、再現可能な診断を保証します。たとえば、2023年 11月に、Dedalus &Ibex Medical Analyticsは、欧州全土のがん診断向けに統合されたエンドツーエンドのAIを活用したデジタル病理ソリューションを導入しました。このソリューションは、精度の向上、AIを活用した意思決定支援ツールの提供、レポートの合理化、検査室の効率の向上、診断の信頼性の向上を目的としています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界のがん診断におけるAI市場、コンポーネント別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• ソフトウェアソリューション
• ハードウェア
• サービス
• 世界のがん診断におけるAI市場、がんタイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 乳がん
• 肺がん
• 脳腫瘍
• 皮膚がんと子宮頸がん
• 前立腺がんと結腸直腸がん
• 他の種類のがん
• 世界のがん診断におけるAI市場、用途別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• スクリーニングと診断
• 腫瘍の特定
• 監視
• 世界のがん診断におけるAI市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 病院
• 診断センター
• 医療研究機関
• 受託研究機関

第7章 地域および国の分析

• 世界のがん診断におけるAI市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
• 世界のがん診断におけるAI市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 市場の競合情勢
• 市場企業プロファイル
  • Microsoft Corporation
  • IBM Corporation
  • Babylon Healthcare Services Ltd.
  • Verily Life Sciences LLC
  • Tempus

第31章 その他の主要および革新的な企業

• Guardant Health
• Lunit Inc.
• Paige AI Inc.
• Ada Health GmbH
• Viz.ai Inc.
• Butterfly Network Inc.
• Insilico Medicine
• BenevolentAI SA
• Enlitic Inc.
• Ibex Medical Analytics
• Kheiron Medical Technologies Limited
• CureMetrix Inc.
• CancerIQ Inc.
• MultiplAI Health
• Freenome Holdings Inc.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

AI in cancer diagnostics involves employing artificial intelligence technologies such as machine learning and deep learning to analyze medical images, genetic data, or patient histories for aiding in the early detection, diagnosis, and prognosis of cancer. These systems can detect patterns and anomalies in data that may elude human perception, thereby enhancing diagnostic accuracy and efficiency.

The primary components of AI in cancer diagnostics include software solutions, hardware, and services. Software solutions utilize artificial intelligence (AI) and machine learning (ML) technologies to enhance the accuracy and efficiency of cancer detection, prognosis, and treatment selection. Various types of cancer, including breast cancer, lung cancer, brain tumors, skin cancer, cervical cancer, prostate cancer, colorectal cancer, and others, are addressed. These applications encompass screening and diagnosis, tumor identification, and monitoring, and are utilized by a range of end-users such as hospitals, diagnostic centers, medical research institutes, and contract research organizations.

The AI in cancer diagnostics market research report is one of a series of new reports from The Business Research Company that provides AI in cancer diagnostics market statistics, including AI in cancer diagnostics industry global market size, regional shares, competitors with an AI in cancer diagnostics market share, detailed AI in cancer diagnostics market segments, market trends, and opportunities, and any further data you may need to thrive in the AI in cancer diagnostics industry. This AI in cancer diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The AI in cancer diagnostics market size has grown exponentially in recent years. It will grow from $0.55 billion in 2023 to $0.66 billion in 2024 at a compound annual growth rate (CAGR) of 20.5%. Historical growth can be attributed to increasing cancer incidence rates, a surge in healthcare data, a supportive regulatory environment, a focus on precision medicine, and the expansion of AI applications beyond imaging.

The AI in cancer diagnostics market size is expected to see exponential growth in the next few years. It will grow to $1.38 billion in 2028 at a compound annual growth rate (CAGR) of 20.3%. Forecasted growth can be attributed to the emergence of explainable AI, a global increase in healthcare IT spending, integration with electronic health records (EHR), adoption of personalized medicine, and ongoing advancements in AI algorithms. Major trends in the forecast period include advancements in imaging technologies, technological convergence, collaborations between healthcare and tech companies, the rise of digital pathology, and automation in histopathology.

The rising prevalence of cancer is anticipated to drive the growth of artificial intelligence (AI) in the cancer diagnostics market in the future. Cancer encompasses a group of diseases characterized by abnormal cell growth, potentially leading to invasion or metastasis. The integration of AI in cancer diagnostics aims to enhance efficiency, accuracy, and personalized treatment options, ultimately improving outcomes for cancer patients. For example, according to the National Library of Medicine, the global cancer burden is projected to reach 28.4 million cases by 2040, marking a 47% increase from 2020, with a significant number of associated deaths. Hence, the growing prevalence of cancer is a key factor propelling the expansion of artificial intelligence in the cancer diagnostics market.

Leading companies in the AI in cancer diagnostics market are experiencing notable growth driven by advancements in AI-powered digital pathology solutions for cancer diagnosis. These solutions utilize AI algorithms to detect cancer and other diagnostic features in various tissue types, offering accurate and timely cancer diagnosis, supporting case prioritization, and ensuring reproducible diagnoses. For instance, in November 2023, Dedalus & Ibex Medical Analytics introduced an integrated End-to-End AI-powered digital pathology solution for cancer diagnosis across Europe. This solution aims to enhance accuracy, provide AI-powered decision support tools, streamline reporting, improve laboratory efficiency, and boost diagnostic confidence.

In December 2023, Lunit, a South Korean AI company, acquired Volpara for $193 million, aiming to establish the combined entity as a leading force in AI-driven cancer diagnostics, particularly in the U.S. market. Volpara's extensive presence in over 2,000 medical sites across the U.S. and its vast database of over 100 million high-quality mammogram images position it as a valuable addition to Lunit's capabilities. Volpara, based in New Zealand, specializes in providing AI-powered software for personalized screening and early detection of breast cancer.

Major companies operating in the AI in cancer diagnostics market report are Microsoft Corporation, IBM Corporation, Babylon Healthcare Services Ltd., Verily Life Sciences LLC, Tempus, Guardant Health, Lunit Inc., Paige AI Inc., Ada Health GmbH, Viz.AI Inc., Butterfly Network Inc., Insilico Medicine, BenevolentAI SA, Enlitic Inc., Ibex Medical Analytics, Kheiron Medical Technologies Limited, CureMetrix Inc., CancerIQ Inc., MultiplAI Health, Freenome Holdings Inc., SkinVision, Entopsis, Owkin, Imagen Technologies, Panakeia Technologies, EchoPixel Inc., X-Zell Inc., Cyrcadia Health, Oncora Medical, Xilis

North America was the largest region in the artificial intelligence in cancer diagnostics market in 2023. The regions covered in the AI in cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the AI in cancer diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

AI in the cancer diagnostics market consists of revenues earned by entities by providing services such as early detection and screening, image analysis and interpretation, predictive analytics, and treatment planning. The market value includes the value of related goods sold by the service provider or included within the service offering. The AI in Cancer Diagnostics market also consists of sales of medical imaging devices, pathology analysis systems, genomic sequencing equipment, and patient monitoring devices that are used in providing services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

AI In Cancer Diagnostics Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on ai in cancer diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for ai in cancer diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The ai in cancer diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Component: Software Solutions; Hardware; Services
• 2) By Cancer Type: Breast Cancer; Lung Cancer; Brain Tumor; Skin Cancer And Cervical Cancer; Prostate And Colorectal Cancer; Other Cancer Types
• 3) By Application: Screening And Diagnosis; Tumor Identification; Monitoring
• 4) By End User: Hospitals; Diagnostic Centers; Medical Research Institutes; Contract Research Organizations
• Companies Mentioned: Microsoft Corporation; IBM Corporation; Babylon Healthcare Services Ltd.; Verily Life Sciences LLC; Tempus
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. AI In Cancer Diagnostics Market Characteristics

3. AI In Cancer Diagnostics Market Trends And Strategies

4. AI In Cancer Diagnostics Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global AI In Cancer Diagnostics Market Size and Growth

• 5.1. Global AI In Cancer Diagnostics Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global AI In Cancer Diagnostics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global AI In Cancer Diagnostics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. AI In Cancer Diagnostics Market Segmentation

• 6.1. Global AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Software Solutions
• Hardware
• Services
• 6.2. Global AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Breast Cancer
• Lung Cancer
• Brain Tumor
• Skin Cancer And Cervical Cancer
• Prostate And Colorectal Cancer
• Other Cancer Types
• 6.3. Global AI In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Screening And Diagnosis
• Tumor Identification
• Monitoring
• 6.4. Global AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals
• Diagnostic Centers
• Medical Research Institutes
• Contract Research Organizations

7. AI In Cancer Diagnostics Market Regional And Country Analysis

• 7.1. Global AI In Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global AI In Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific AI In Cancer Diagnostics Market

• 8.1. Asia-Pacific AI In Cancer Diagnostics Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China AI In Cancer Diagnostics Market

• 9.1. China AI In Cancer Diagnostics Market Overview
• 9.2. China AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India AI In Cancer Diagnostics Market

• 10.1. India AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan AI In Cancer Diagnostics Market

• 11.1. Japan AI In Cancer Diagnostics Market Overview
• 11.2. Japan AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia AI In Cancer Diagnostics Market

• 12.1. Australia AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia AI In Cancer Diagnostics Market

• 13.1. Indonesia AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea AI In Cancer Diagnostics Market

• 14.1. South Korea AI In Cancer Diagnostics Market Overview
• 14.2. South Korea AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe AI In Cancer Diagnostics Market

• 15.1. Western Europe AI In Cancer Diagnostics Market Overview
• 15.2. Western Europe AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK AI In Cancer Diagnostics Market

• 16.1. UK AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany AI In Cancer Diagnostics Market

• 17.1. Germany AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France AI In Cancer Diagnostics Market

• 18.1. France AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy AI In Cancer Diagnostics Market

• 19.1. Italy AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain AI In Cancer Diagnostics Market

• 20.1. Spain AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe AI In Cancer Diagnostics Market

• 21.1. Eastern Europe AI In Cancer Diagnostics Market Overview
• 21.2. Eastern Europe AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia AI In Cancer Diagnostics Market

• 22.1. Russia AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America AI In Cancer Diagnostics Market

• 23.1. North America AI In Cancer Diagnostics Market Overview
• 23.2. North America AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA AI In Cancer Diagnostics Market

• 24.1. USA AI In Cancer Diagnostics Market Overview
• 24.2. USA AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada AI In Cancer Diagnostics Market

• 25.1. Canada AI In Cancer Diagnostics Market Overview
• 25.2. Canada AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America AI In Cancer Diagnostics Market

• 26.1. South America AI In Cancer Diagnostics Market Overview
• 26.2. South America AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil AI In Cancer Diagnostics Market

• 27.1. Brazil AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East AI In Cancer Diagnostics Market

• 28.1. Middle East AI In Cancer Diagnostics Market Overview
• 28.2. Middle East AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa AI In Cancer Diagnostics Market

• 29.1. Africa AI In Cancer Diagnostics Market Overview
• 29.2. Africa AI In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa AI In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa AI In Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. AI In Cancer Diagnostics Market Competitive Landscape And Company Profiles

• 30.1. AI In Cancer Diagnostics Market Competitive Landscape
• 30.2. AI In Cancer Diagnostics Market Company Profiles
  • 30.2.1. Microsoft Corporation
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. IBM Corporation
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Babylon Healthcare Services Ltd.
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Verily Life Sciences LLC
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Tempus
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. AI In Cancer Diagnostics Market Other Major And Innovative Companies

• 31.1. Guardant Health
• 31.2. Lunit Inc.
• 31.3. Paige AI Inc.
• 31.4. Ada Health GmbH
• 31.5. Viz.ai Inc.
• 31.6. Butterfly Network Inc.
• 31.7. Insilico Medicine
• 31.8. BenevolentAI SA
• 31.9. Enlitic Inc.
• 31.10. Ibex Medical Analytics
• 31.11. Kheiron Medical Technologies Limited
• 31.12. CureMetrix Inc.
• 31.13. CancerIQ Inc.
• 31.14. MultiplAI Health
• 31.15. Freenome Holdings Inc.

32. Global AI In Cancer Diagnostics Market Competitive Benchmarking

33. Global AI In Cancer Diagnostics Market Competitive Dashboard

34. Key Mergers And Acquisitions In The AI In Cancer Diagnostics Market

35. AI In Cancer Diagnostics Market Future Outlook and Potential Analysis

• 35.1 AI In Cancer Diagnostics Market In 2028 - Countries Offering Most New Opportunities
• 35.2 AI In Cancer Diagnostics Market In 2028 - Segments Offering Most New Opportunities
• 35.3 AI In Cancer Diagnostics Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer